Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 6.997M
December 31, 2025 5.234M
June 30, 2025 6.352M
December 31, 2024 6.961M
June 30, 2024 5.044M
December 31, 2023 5.052M
June 30, 2023 5.945M
December 31, 2022 6.297M
June 30, 2022 6.731M
December 31, 2021 6.394M
June 30, 2021 5.506M
December 31, 2020 7.738M
Date Value
June 30, 2020 10.54M
December 31, 2019 9.994M
June 30, 2019 10.64M
December 31, 2018 12.49M
June 30, 2018 11.79M
December 31, 2017 10.73M
June 30, 2017 11.16M
December 31, 2016 8.809M
June 30, 2016 9.144M
December 31, 2015 9.024M
June 30, 2015 4.897M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
NuCana Plc 10.70M
Mereo BioPharma Group Plc 12.83M
BioNTech SE 2.378B
Silence Therapeutics Plc 34.11M
Autolus Therapeutics Plc 115.59M